Andrographolide is one of principal constituents of a famous traditional Chinese herbal medicine Andrographis paniculate (BURM) NEES. Its chemical structure is 2(3H)-furanone, 3-[2-[decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-napthalenyl] ethylidene] dihydro-4-hydroxy. Andrographolide has many bioactivities, such as antiinflammatory, [1] [2] [3] anti-allergic, 4, 5) anti-platelet aggregation, 6) hepatoprotective 7, 8) and anti-human immunodeficiency virus (HIV) activities.
Andrographolide is one of principal constituents of a famous traditional Chinese herbal medicine Andrographis paniculate (BURM) NEES. Its chemical structure is 2(3H)-furanone, 3-[2-[decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-napthalenyl] ethylidene] dihydro-4-hydroxy. Andrographolide has many bioactivities, such as antiinflammatory, [1] [2] [3] anti-allergic, 4, 5) anti-platelet aggregation, 6 ) hepatoprotective 7, 8) and anti-human immunodeficiency virus (HIV) activities. 9, 10) And this compound has been widely used in clinic for the treatment of fever, cold, inflammation, diarrhea and other infectious diseases. The pharmacokinetic studies showed that andrographolide was quickly absorbed and intensely metabolized in rats and humans. 11) One of the metabolites of it after oral administration in rats was determined as 14-deoxy-12(R)-sulfoandrographolide, which was found to be identical to an antiinflammatory drug (Lianbizhi) currently being used in clinic as injection in China. 12, 13) Therefore, the metabolites of andrographolide in human urine were further investigated and four sulfate conjugates were obtained. The present paper describes the extraction, isolation and identification of these metabolites.
Metabolite 1 (M-1), white amorphous powder, was positive to the Legal and Kedde reactions, suggesting the presence of an a,b-unsaturated lactone. The IR spectrum showed the presence of hydroxyl (3421 cm
Ϫ1
) and ester carbonyl (1736, 1670 cm Ϫ1 ) groups in the molecule. The high-resolution FAB-MS showed the quasi-molecular ion [MϪH] Ϫ at m/z 429.1583 (Calcd 429.1588), corresponding to the molecular formula C 20 H 30 O 8 S, which was further supported by the 1 H-and 13 C-NMR spectral data. Metabolite 1 was a 80 mass unit (SO 3 ) higher than that of andrographolide, suggesting it was a sulfate conjugate. The 13 C-NMR data of M-1 were similar to those of the parent drug andrographolide, except for the downfield shifts of C-3 by 7.1 ppm and the upfield shifts of C-2 by 3.2 ppm, respectively. In the HMBC spectrum, H-3 ( Based on the above data, metabolite 1 was determined to be andrographolide-3-O-sulfate. The full assignments of carbon and proton signals are summarized in Table 1 .
Metabolite 2 (M-2), white amorphous powder, was positive to the Legal and Kedde reactions. In the IR spectrum, the absorption at 3421 cm Ϫ1 was the absorption of the hydroxyl group while the absorption at 1747 and 1670 cm Ϫ1 were the absorption of the ester carbonyl group. In the high-resolution FAB-MS, a quasi-molecular peak [MϪH] Ϫ at m/z 429.1589 (Calcd 429.1588) was observed, and thus the molecular formula of C 20 H 30 O 8 S was derived. The assignment of this formula was further supported by the Based on the above analysis, M-2 was determined to be isoandrographolide-3-O-sulfate except for the absolute configuration at C-14. The full assignments of carbon and proton signals were summarized in Table 1 .
Metabolite 3 (M-3), white amorphous powder, was positive to the Legal and Kedde reactions. There were hydroxyl absorption at 3445 cm Ϫ1 and the ester carbonyl at 1751 cm
in the IR spectrum. In the negative ESI-MS, the molecular ion peak was shown at m/z 414. Thus the molecular formula was determined to be C 20 H 30 O 7 S with combination of the 1 Hand 13 C-NMR spectral data. Metabolite 3 was a 16 mass unit less than that of metabolite 1, suggesting metabolite 3 might be a deoxygenated sulfate conjugate. 13 C-NMR of metabolite 1 and metabolite 3 showed similarities except for the chemical shifts at C-9 and C-11 to C-16, in which the hydroxyllinked carbon signal at d 66.6 (C-14) of metabolite 1 disappeared and a new carbon signal of methylene at d 25.3 (C-12) was observed. This confirmed that metabolite 3 was a deoxygenated sulfate conjugate. In the These data suggested the structure of the lactone side chain moiety. In compassion with metabolite 1, the double bond of metabolite 3 had transferred from the outside to inside of the lactone ring and the hydroxyl group at C-14 of metabolite 1 disappeared in metabolite 3. In the UV spectrum, the maximal absorption of metabolite 3 was at 203 nm, which was different from that of andrographolide at 225. The hypsochromic shift in UV spectrum also supported the change of conjugated system.
Based on chemical and spectroscopic analyses, M-3 was determined to be 14-deoxyandrographolide-3-O-sulfate. The full assignments of carbon and proton signals were summarized in Table 2 .
Metabolite 4 (M-4), white amorphous power, was positive to the Legal and Kedde reactions. The IR spectrum showed the presence of hydroxyl (3445 cm No.
Carbon signals Proton signals
c-e) From the above analyses, metabolite 4 was determined to be 14-deoxy-12-(cysteine-S-yl)-andrographolide-3-O-sulfate except for the absolute configuration at C-12. The full assignments of carbon and proton signals were summarized in Table 2 .
Experimental
General Experimental Procedure IR spectra were determined on a SHIMADZU FT/IR-8400 spectrometer in KBr pellets. UV spectra were measured on a Shimadzu UV-2201 spectrometer. ESI-MS spectra were recorded on a Bruker esquire 2000 mass spectrometer. HR-FAB-MS were recorded in on a Bruker second ionization mass spectrometer. NMR spectra were measured on Bruker AV-400 or Bruker ARX-300 spectrometers, using TMS as an internal standard.
Silica gel for column chromatography (200-300 mesh), and silica gel G 60 and GF 254 for thin-layer chromatography were products of Qingdao Marine Chemical Factory. Normal-phase and reverse-phase preparatory TLC was performed using products from Merck Company. D101 were purchased from Tianjing and Rensui, respectively. Sephadex ® LH-20 and ODS were the products of Pharmacia Company. Preparative HPLC was performed using an C-8 column (C-8, 250ϫ20 mm, Inertsil Pak; detector: UV).
Subjects and Dosing Procedure Eight healthy volunteers aged 21 to 28 years and weighed 50 to 80 kg (all males) participated in this study. Each subject was given orally 3 tablets 3 times per day (50 mg of andrographolide per tablet) for 2 d and the urine was collected between 0 to 72 h.
Extraction and Isolation The urine samples (approximately 50000 ml in total) were concentrated to almost dryness in vacuo after collection. The residue was suspended in water and partitioned with ethyl acetate and n-butanol for 3 times, respectively. The butanol layer was subjected to D101 and eluted with H 2 O/EtOH stepwisely. The 50% EtOH eluate was further subjected to ODS, Sephadex LH-20 and finally purified by preparative HPLC to yield 5.5 mg of metabolite 1, 6.2 mg of metabolite 2 and 3.0 mg of metabolite 3. The water layer was treated in a similar fashion to give 2. 
